Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +15.09% | +17.39% | -21.71% |
04-25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
04-25 | Transcript : OptiNose, Inc. - Special Call |
Chart calendar OptiNose, Inc.
Upcoming events on OptiNose, Inc.
Past events on OptiNose, Inc.
2024-04-25 10:00 | Business Update Call |
2024-04-10 14:15 | Needham Healthcare Conference |
2024-03-07 08:00 | Q4 2023 Earnings Call |
2024-03-07 07:00 | Q4 2023 Earnings Release |
2023-11-29 15:30 | Piper Sandler Healthcare Conference |
2023-11-09 08:00 | Q3 2023 Earnings Call |
2023-11-09 07:00 | Q3 2023 Earnings Release |
2023-09-27 16:45 | Cantor Global Healthcare Conference |
2023-08-10 08:00 | Q2 2023 Earnings Call |
2023-08-10 07:00 | Q2 2023 Earnings Release |
2023-06-09 10:00 | Jefferies Global Healthcare Conference |
2023-06-08 08:30 | Annual General Meeting |
2023-05-11 08:00 | Q1 2023 Earnings Call |
2023-05-11 07:00 | Q1 2023 Earnings Release |
2023-04-17 15:45 | Needham Healthcare Conference |
2023-03-07 08:00 | Q4 2022 Earnings Call |
2023-03-07 07:00 | Q4 2022 Earnings Release |
2022-12-01 12:30 | Piper Sandler Healthcare Conference |
2022-11-12 12:05 | American College of Asthma, Allergy, and Immunology Scientific Meeting - Poster No 217 |
2022-11-10 08:00 | Q3 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 34,6 35,2 -1.52% | 49,1 50,8 -3.24% | 74,7 73,9 1.02% | 76,3 76,1 0.24% | 71,0 70,3 0.92% | 90,5 |
EBITDA Million USD | Released Forecast Spread | -84,6 -86,7 2.41% | -85,8 -78,1 -9.81% | -65,8 -59,9 -9.8% | -55,4 -52,7 -5.06% | -22,3 -19,6 -13.74% | -4,00 |
EBIT Million USD | Released Forecast Spread | -95,6 -97,3 1.71% | -87,2 -86,4 -0.99% | -66,5 -68,1 2.45% | -55,9 -58,8 4.94% | -22,7 -26,2 13.21% | -11,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -110 -111 1.24% | -99,8 -98,3 -1.49% | -82,3 -83,6 1.51% | -74,8 -72,2 -3.65% | -35,5 -36,1 1.7% | -30,5 |
Net income Million USD | Released Forecast Spread | -110 -111 1.24% | -99,8 -98,3 -1.49% | -82,3 -83,6 1.53% | -74,8 -72,2 -3.65% | -35,5 -36,1 1.7% | -30,5 |
EPS USD | Released Forecast Spread | -2,63 -2,66 1.22% | -2,07 -2,07 0.12% | -1,45 -1,46 0.96% | -0,87 -0,86 -1.46% | -0,32 -0,32 1.03% | -0,26 |
Announcement Date | 05/03/20 | 03/03/21 | 08/03/22 | 07/03/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22,5 21,8 3.49% | 14,8 16,7 -11.66% | 20,6 21,5 -4.27% | 20,1 23,4 -14.2% | 20,9 20,7 0.81% | 11,8 10,2 16.14% | 19,5 17,0 14.44% | 19,8 18,5 7.44% | 19,9 19,2 3.46% | 13,7 | 21,0 | 24,8 | 32,9 | 24,5 |
EBITDA Million USD | Released Forecast Spread | -11,5 -8,80 -30.62% | -19,3 -17,0 -13.67% | -8,22 -5,64 -45.71% | |||||||||||
EBIT Million USD | Released Forecast Spread | -11,7 -13,9 15.95% | -21,4 -18,5 -15.81% | -15,3 -16,3 5.71% | -10,8 -11,8 8.22% | -8,36 -11,2 25.49% | -14,4 -13,5 -6.43% | -4,17 -7,00 40.4% | -1,69 -6,15 72.46% | -2,51 -6,05 58.48% | -8,23 | -5,49 | -1,68 | 3,07 | -3,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,6 -17,5 10.54% | -25,3 -22,1 -14.43% | -19,4 -20,1 3.5% | -15,0 -15,7 4.55% | -15,1 -15,5 2.29% | -18,8 -17,7 -6.48% | 2,63 -11,8 122.25% | -9,29 -10,6 12.32% | -9,97 -10,6 5.97% | -12,8 | -10,1 | -6,32 | -1,55 | -7,70 |
Net income Million USD | Released Forecast Spread | -15,6 -17,5 10.54% | -25,3 -22,1 -14.43% | -19,4 -20,1 3.5% | -15,0 -15,7 4.55% | -15,1 -15,5 2.29% | -18,8 -17,7 -6.48% | 2,57 -11,8 121.81% | -9,29 -10,6 12.32% | -9,97 -10,6 5.97% | -12,8 | -10,1 | -6,32 | -1,55 | -7,70 |
EPS USD | Released Forecast Spread | -0,23 -0,26 11.54% | -0,31 -0,27 -14.81% | -0,23 -0,24 5.15% | -0,18 -0,18 2.17% | -0,17 -0,18 2.86% | -0,17 -0,14 -21.43% | 0,02 -0,11 118.18% | -0,08 -0,09 14.28% | -0,09 -0,09 3.57% | -0,11 | -0,08 | -0,06 | -0,02 | -0,06 |
Announcement Date | 08/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 07/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | - | - | - | - | - |
Past sector events for OptiNose, Inc.
2024-05-03 07:07 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
2024-05-03 06:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
2024-05-02 16:01 | AMGEN INC.: Q1 2024 Earnings Release |
2024-05-02 13:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
2024-05-02 07:30 | ORGANON & CO.: Q1 2024 Earnings Release |
2024-05-02 07:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
2024-05-02 01:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OPTN Stock
- Calendar OptiNose, Inc.